EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Analysis of Consensus Molecular Subtypes of Colorectal Cancer in Oman with Clinicopathologic Correlation

Shaista Rehman iD, Asem Shalaby iD, Said A Al-Busafi iD, Moon Fai Chan iD, Shaima Al Khabouri iD, Mustafa Al Hinai, Adhari Al Zaabi iD, Mohammad Al Masqari iD, Asim Qureshi iD, Mohammed Al-Azri iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27042038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Shaista Rehman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine and Public Health, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oman (HIS Majesty (HM) Strategic Grant), His Majesty (HM) Strategic Grants.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a major public health challenge in Oman and a leading cause of cancer-related mortality. The rising incidence has been associated with lifestyle changes, urbanization, and genetic factors. The CRC Subtyping Consortium has defined four consensus molecular subtypes (CMS1–CMS4); however, data on their distribution in the Gulf region, including Oman, remain limited. This study aimed to characterize the distribution of CMS subtypes in Omani CRC patients and assess their clinicopathologic correlations using a practical immunohistochemistry (IHC) panel supplemented by a limited targeted molecular approach. This study included 273 CRC patients diagnosed between 2023 and 2024 at two major referral hospitals in Muscat. Initially, the mismatch repair (MMR)-deficient tumors (dMMR) were assigned as CMS1, while the MMR-proficient (pMMR) tumors were further evaluated for β-catenin, P53, KRAS, and TGF-β expression. Mutations in BRAF, TP53, and KRAS were analyzed by sequencing. The cohort comprised 51.6% males, with a mean age of 59.1 years. Most tumors were left-sided (70.7%). dMMR (CMS1) comprised 31 cases (11.35%). Out of the pMMR tumors, 111 cases (40.65%) showed positive expression of β-catenin and P53 (CMS2), 63 cases (23.0%) showed KRAS mutations (CMS3), and 68 cases (24.9%) showed TGF-β-positive expression (CMS4). The cases were predominantly concentrated in Muscat (41%). This study demonstrated the feasibility and clinical relevance of CMS-based classification in Oman and its potential role in precision oncology and healthcare planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsHumansOmanMaleFemaleMiddle AgedMutationAgedBiomarkers, TumorDNA Mismatch RepairImmunohistochemistryAdultTumor Suppressor Protein p53Proto-Oncogene Proteins p21(ras)Proto-Oncogene Proteins B-rafbeta Catenin

Stichwörter der Autor:innen

Omancolorectal cancerconsensus molecular subtypesimmunohistochemistrymolecular testing

Substanzen

Biomarkers, TumorTumor Suppressor Protein p53Proto-Oncogene Proteins p21(ras)Proto-Oncogene Proteins B-rafbeta Catenin

Autor:innen und Institutionen

  • Department of Family Medicine and Public Health, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman.
  • Department of Pathology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman.
  • Department of Pathology, College of Medicine, Mansoura University, Mansoura 1156, Egypt.
  • Gastroenterology and Hepatology Unit, Department of Medicine, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman.
  • Medical Research Center, Sultan Qaboos University, Muscat 123, Oman.
  • Department of Medicine, Faculty of Medicine and Health, Sepuluh Nopember Institute of Technology, Surabaya 60111, Indonesia.

ORCID-Profile: Shaista Rehman, Asem Shalaby, Said A Al-Busafi, Moon Fai Chan, Shaima Al Khabouri, Adhari Al Zaabi, Mohammad Al Masqari, Asim Qureshi, Mohammed Al-Azri

Förderung

  • Oman (HIS Majesty (HM) Strategic Grant)
  • His Majesty (HM) Strategic Grants

Zitieren

APA

Rehman, S., Shalaby, A., Al-Busafi, S. A., Chan, M. F., Al Khabouri, S., Al Hinai, M., Al Zaabi, A., Al Masqari, M., Qureshi, A., & Al-Azri, M. (2026). Analysis of Consensus Molecular Subtypes of Colorectal Cancer in Oman with Clinicopathologic Correlation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27042038

Vancouver

Rehman S, Shalaby A, Al-Busafi SA, Chan MF, Al Khabouri S, Al Hinai M, et al. Analysis of Consensus Molecular Subtypes of Colorectal Cancer in Oman with Clinicopathologic Correlation. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27042038

BibTeX
@article{Rehman2026,
  author = {Rehman, Shaista and Shalaby, Asem and Al-Busafi, Said A and Chan, Moon Fai and Al Khabouri, Shaima and Al Hinai, Mustafa and Al Zaabi, Adhari and Al Masqari, Mohammad and Qureshi, Asim and Al-Azri, Mohammed},
  title = {Analysis of Consensus Molecular Subtypes of Colorectal Cancer in Oman with Clinicopathologic Correlation},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27042038}
}
Kostenlos starten →